Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026)
Apyx Medical (APYX) reported Cash from Financing Activities of $83000.0 for Q1 2026, up 232.0% on a YoY basis from $25000.0 in Q1 2025, and down 99.12% quarter-over-quarter from $9.5 million in Q4 2025.
Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Apyx Medical has reported Cash from Financing Activities for 16 years, with the latest figure at $83000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 232.0% year-over-year to $83000.0; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (up 42.26% YoY), and the FY2025 full-year result was $9.6 million, up 42.03% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $83000.0, down from $9.5 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $23.8 million in Q4 2023, with the low at -$10000.0 in Q4 2022.
- Historically, Cash from Financing Activities has averaged $2.9 million across 5 years, with a median of $46000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 238540.0% — and 2024, when it plunged 110.87%.
- Apyx Medical's Cash from Financing Activities stood at -$10000.0 in 2022, then soared by 238540.0% to $23.8 million in 2023, then tumbled by 71.65% to $6.8 million in 2024, then soared by 40.31% to $9.5 million in 2025, then slumped by 99.12% to $83000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $83000.0 (Q1 2026), $9.5 million (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Apyx Medical | 179.34 Mn | 148.46 Mn | 7.93 Mn | 83,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 9.49 Mn |
| Dec 31, 2025 | 9.49 Mn |
| Sep 30, 2025 | 45,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 6.76 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 23.84 Mn |
| Dec 31, 2023 | 23.84 Mn |